Study of CM326 Injection in Healthy Subjects

Summary

This study is a single-center, randomized, double-blind, placebo-controlled, dose-increasing phase I clinical study.

Timeline

Start

2023-03-21

Primary completion

2023-10-04

Completion

2023-10-04

Publications

• Di Y, Yang L, Zhou J, Zhang L, Huang Y, Jia Y, Yan H, Chen L, Hou Q, Chen B, Luo Z, Hou J. Translational Investigation of CM326 from Preclinical Studies to Randomized Phase I Clinical Trials in Healthy Adults. BioDrugs. 2025 May;39(3):487-498. doi: 10.1007/s40259-025-00714-4. Epub 2025 Apr 4.

Drugs

Indications

No indication recorded.